2 insiders reported 6 Form 4 transactions for Cue Biopharma, Inc. (CUE) over the past 18 months (most recent 2026-05-07). Recent activity: Lin Shao-Lee (CHIEF EXECUTIVE OFFICER) Buy 327,537 shares, Sarraf Pasha (Director) Buy 4,229 shares, Sarraf Pasha (Director) Buy 77,148 shares, Sarraf Pasha (Director) Buy 86,947 shares, Sarraf Pasha (Director) Buy 78,116 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | Lin Shao-Lee | CHIEF EXECUTIVE OFFICER | Buy | 327,537 | $0 |
| 2026-01-02 | Sarraf Pasha | Director | Buy | 4,229 | $1,311 |
| 2026-01-02 | Sarraf Pasha | Director | Buy | 77,148 | $23,144 |
| 2026-01-02 | Sarraf Pasha | Director | Buy | 86,947 | $27,823 |
| 2026-01-02 | Sarraf Pasha | Director | Buy | 78,116 | $24,216 |
| 2026-01-02 | Sarraf Pasha | Director | Buy | 77,417 | $23,225 |
Source: SEC Form 4 filings · as of 2026-05-07